Anti-inflammatory effects of propofol during cardiopulmonary bypass: A pilot study

Annals of Cardiac Anaesthesia

Volumn 18, Issue 4, 2015, Pages 495-501

  Samir, A ^a   Gandreti, N ^a   Madhere, M ^a   Khan, A ^a   Brown, M ^a   Loomba, V ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Cardiopulmonary bypass; Coronary artery bypass graft; Interleukin; Propofol

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PROPOFOL; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; INTRAVENOUS ANESTHETIC AGENT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; LOW DRUG DOSE; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; ANALYSIS OF VARIANCE; FEMALE; MALE;

ANALYSIS OF VARIANCE; ANESTHETICS, INTRAVENOUS; ANTI-INFLAMMATORY AGENTS; CARDIOPULMONARY BYPASS; FEMALE; HUMANS; INFLAMMATION; MALE; PILOT PROJECTS; PROPOFOL; PROSPECTIVE STUDIES;

EID: 84944752939     PISSN: 09719784     EISSN: 09745181     Source Type: Journal    
DOI: 10.4103/0971-9784.166451     Document Type: Article

References (34)

1. Despotis GJ, Avidan MS, Hogue CW Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001;72:S1821-31.
2. Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 2001;71:745-54.
3. Diegeler A, Doll N, Rauch T, Haberer D, Walther T, Falk V, et al. Humoral immune response during coronary artery bypass grafting: A comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass. Circulation 2000;102 19 Suppl 3:III95-100.
4. Lim KH, Hale strap AP, Angelini GD, Suleiman MS. Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass. Exp Biol Med (Maywood) 2005;230:413-20.
5. Breisblatt WM, Stein KL, Wolfe CJ, Follansbee WP, Capozzi J, Armitage JM, et al. Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery. J Am Coll Cardiol 1990;15:1261-9.
6. Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med 2000;109:315-23.
7. Musacchio E, Rizzoli V, Bianchi M, Bindoli A, Galzigna L. Antioxidant action of propofol on liver microsomes, mitochondria and brain synaptosomes in the rat. Pharmacol Toxicol 1991;69:75-7.
8. Petros AJ, Bogle RG, Pearson JD. Propofol stimulates nitric oxide release from cultured porcine aortic endothelial cells. Br J Pharmacol 1993;109:6-7.
9. Mathy-Hartert M, Mouithys-Mickalad A, Kohnen S, Deby-Dupont G, Lamy M, Hans P. Effects of propofol on endothelial cells subjected to a peroxynitrite donor (SIN-1). Anaesthesia 2000;55:1066-71.
10. Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, et al. Propofol inhibits human neutrophil functions. Anesth Analg 1998;87:695-700.
11. Corcoran TB, Engel A, Sakamoto H, O'Callaghan-Enright S, O'Donnell A, Heffron JA, et al. The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting. J Cardiothorac Vasc Anesth 2004;18:592-604.
12. Ozaki M. The effects of propofol and midazolam on canine left ventricular contractility. Masui 2002;51:611-9.
13. De Hert SG, ten Broecke PW, Mertens E, Van Sommeren EW, De Blier IG, Stockman BA, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002;97:42-9.
14. De Hert SG. Study on the effects of six intravenous anesthetic agents on regional ventricular function in dogs (thiopental, etomidate, propofol, fentanyl, sufentanil, alfentanil). Acta Anaesthesiol Belg 1991;42:3-39.
15. Royse CF, Liew DF, Wright CE, Royse AG, Angus JA. Persistent depression of contractility and vasodilation with propofol but not with sevoflurane or desflurane in rabbits. Anesthesiology 2008;108:87-93.
16. Kam PC, Cardone D. Propofol infusion syndrome. Anaesthesia 2007;62:690-701.
17. Rajda C, Dereczyk D, Kunkel P. Propofol infusion syndrome. J Trauma Nurs 2008;15:118-22.
18. Fransen EJ, Maessen JG, Hermens WT, et al. Perioperative myocardial tissue injury and the release of inflammatory mediators in coronary artery bypass graft patients. Cardiovasc Res 2000;45:853-9.
19. Brasil LA, Gomes WJ, Salomão R, Buffolo E. Inflammatory response after myocardial revascularization with or without cardiopulmonary bypass.The Annals of thoracic surgery 1998;66:56-9.
20. Tárnok A, Hambsch J, Emmrich F, Sack U, van Son J, Bellinghausen W, et al. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass. Pediatr Cardiol 1999;20:113-25.
21. Ascione R, Lloyd CT, Underwood MJ, Gomes WJ, Angelini GD. On-pump versus off-pump coronary revascularization: Evaluation of renal function. Ann Thorac Surg 1999;68:493-8.
22. Chen RM, Wu CH, Chang HC, Wu GJ, Lin YL, Sheu JR, et al. Propofol suppresses macrophage functions and modulates mitochondrial membrane potential and cellular adenosine triphosphate synthesis. Anesthesiology 2003;98:1178-85.
23. Chen RM, Chen TG, Chen TL, et al. Anti inflamatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. Ann N Y Acad Sci 2005;262-71.
24. Chang H, Tsai SY, Chang Y, Chen TL, Chen RM. Therapeutic concentrations of propofol protects mouse macrophages from nitric oxide-induced cell death and apoptosis. Can J Anaesth 2002;49:477-80.
25. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: A simple name for a complex syndrome. Intensive Care Med 2003;29:1417-25.
26. Fudickar A, Bein B. Propofol infusion syndrome: Update of clinical manifestation and pathophysiology. Minerva Anestesiol 2009;75:339-44.
27. Hsing CH, Lin MC, Choi PC, Huang WC, Kai JI, Tsai CC, et al. Anesthetic propofol reduces endotoxic inflammation by inhibiting reactive oxygen species-regulated Akt/IKKß/NF-kB signaling. PLoS One 2011;6:e17598.
28. Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992;68:613-8.
29. De La Cruz JP, Sedeño G, Carmona JA, Sánchez de la Cuesta F. The in vitro effects of propofol on tissular oxidative stress in the rat. Anesth Analg 1998;87:1141-6.
30. Mouithys-Mickalad A, Hans P, Deby-Dupont G, Hoebeke M, Deby C, Lamy M. Propofol reacts with peroxynitrite to form a phenoxyl radical: Demonstration by electron spin resonance. Biochem Biophys Res Commun 1998;249:833-7.
31. Hess ML, Okabe E, Kontos HA. Proton and free oxygen radical interaction with the calcium transport system of cardiac sarcoplasmic reticulum. J Mol Cell Cardiol 1981;13:767-72.
32. Kokita N, Hara A, Abiko Y, Arakawa J, Hashizume H, Namiki A. Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg 1998;86:252-8.
33. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997;85:766-82.
34. Zhang SH, Wang SY, Yao SL. Antioxidative effect of propofol during cardiopulmonary bypass in adults. Acta Pharmacol Sin 2004;25:334-40.